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Abstract
Background: Human macrophages (Mw) express low levels of CD4 glycoprotein, which is constitutively recycled, and 40–
50% of its localization is intracellular at steady-state. Although CD4-interacting proteins in lymphoid cells are well
characterised, little is known about the CD4 protein interaction-network in human Mw, which notably lack LCK, a Src family
protein tyrosine kinase believed to stabilise CD4 at the surface of T cells. As CD4 is the main cellular receptor used by HIV-1,
knowledge of its molecular interactions is important for the understanding of viral infection strategies.
Methodology/Principal Findings: We performed large-scale anti-CD4 immunoprecipitations in human primary Mw followed
by high-resolution mass spectrometry analysis to elucidate the protein interaction-network involved in induced CD4
internalization and degradation. Proteomic analysis of CD4 co-immunoisolates in resting Mw showed CD4 association with a
range of proteins found in the cellular cortex, membrane rafts and components of clathrin-adaptor proteins, whereas in
induced internalization and degradation CD4 is associated with components of specific signal transduction, transport and
the proteasome.
Conclusions/Significance: This is the first time that the anti-CD4 co-immunoprecipitation sub-proteome has been analysed
in human primary Mw. Our data have identified important Mw cell surface CD4-interacting proteins, as well as regulatory
proteins involved in internalization and degradation. The data give valuable insights into the molecular pathways involved
in the regulation of CD4 expression in Mw and provide candidates/targets for further biochemical studies.
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Introduction
Mass spectrometry (MS)-based identification of the components
of purified protein complexes has become one of the most
powerful and routinely used technologies for high-throughput
detection of protein interactions [1,2]. The study of protein
interactions by MS for identification of components of protein
complexes gives powerful insights into protein function, binding
partners and cellular pathways [3,4]. In most studies, proteins in a
given complex are identified via MS analysis of in-gel tryptic
digests of electrophoretically separated proteins of particular sub-
cellular fractions (membranes, nuclei, intracellular compartments)
or in co-immunoprecipitated complexes [5,6,7,8].
CD4 is the main cellular receptor used by human immunode-
ficiency viruses HIV-1, HIV-2 and simian immunodeficiency virus
[9,10,11]. It is a type I transmembrane glycoprotein of 55 kDa
expressed on the surface of Regulatory and Helper subsets of T
lymphocytes and interacts with MHC class-II carrying cells [12].
CD4 increases the avidity of the low affinity interactions between
the peptide-MHC complex on antigen presenting cells and the T
cell receptor on the lymphocyte, and its association with the
intracellular protein tyrosine kinase LCK modulates signal
transduction [13]. In humans and rats CD4 is also expressed on
cells of the monocyte/Mw lineage, although its function on these
cells is poorly understood, and the protein expression levels are 10-
to 20-fold less than in T cells [14,15]. In lymphoid cells expressing
LCK, 90% of CD4 is restricted to the cell surface and undergoes
limited internalization [16]. Endocytosis of CD4 can occur,
through clathrin-coated pits, when the cytoplasmic domain
becomes serine phosphorylated, leading to its dissociation from
LCK [17,18,19]. In myeloid cells, such as Mw, which do not
express LCK, CD4 is constitutively internalized and 40–50% is
intracellular at steady-state [16]. The pathways by which CD4 is
removed from the cell surface and the protein-network involved
are poorly defined. Cell surface CD4 levels can be down-regulated
by exposure to gangliosides [20], soluble HIV-1 gp120 [21],
phorbol esters [17,22] and during HIV-1 infection [23,24].
Moreover, down-regulation of viral receptors is a common
mechanism used by most retroviruses to avoid superinfection
(multiple rounds of infection) and to promote viral release. HIV-1
Nef protein accelerates CD4 internalization and degradation in
the lysosomes [25], and at the late stages of HIV-1 infection, CD4
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[26,27,28].
Most reports to date have analysed CD4 interaction complexes
in lymphoid cell lines, revealing some of the well-known
associating proteins, such as LCK, CD45, transferrin receptor
(CD71), CD98, myosins, vimentin, tubulins, actins, annexin II and
lymphocyte phosphatase associated phosphoprotein (LPAP)
[29,30,31,32]. However, little is known about how CD4 antigen
is arranged at the surface of Mw, which notably lack LCK
expression.
In common with other laboratories we found that the kinetics of
HIV-1 replication was modulated by the simultaneous presence of
Mw and T cells in different ratios and activation states [33,34,35].
Data from our laboratory reported that HIV-1 viral production
was typically slower in infected cultures in which Mw were co-
cultured with activated T cells. More recently, we extended these
observations and showed that activated T cells produce soluble
factors that selectively induce the internalization and degradation
of CD4 in primary Mw, thus critically affecting HIV-1 entry in a
process sensitive to the vacuolar ATPase inhibitor bafilomycin A1,
and the proteasomal inhibitor, MG132 (Saraiva Raposo et al.,
manuscript under revision).
In this report we perform high-resolution mass spectrometry
analysis of CD4 co-immunoisolates in human primary Mw,i n
order to characterise the CD4 containing complexes in steady-
state and at different stages of CD4 internalization and
degradation. The experimental strategy is shown in Fig. 1.
Results
Conditioned media from activated T cells induces CD4
internalization and degradation in Mw
In order to effectively demonstrate the induction of CD4
internalization and degradation, we detected the expression of
CD4 in Mw before and after treatment with conditioned media
from activated T cells by flow cytometry. Eighteen hours post-
treatment the expression of CD4 levels at the surface of Mw was
barely detectable (Fig. 2A), and the percentage of Mw expressing
surface CD4 was significantly reduced by 4-fold (Fig. 2B). In
addition, total CD4 expression (surface + intracellular) was
diminished by 2-fold (Fig. 2C). Altogether, these data suggest the
internalization and degradation of CD4 after treatment with
conditioned supernatants from activated T cells.
Anti-CD4 co-immunoprecipitation sub-proteome in
control Mw
We performed large-scale CD4 immunoprecipitations in
normal resting primary human Mw, followed by LC-MS/MS. A
representative gel of the resolved proteins after CD4 co-
immunoisolation is shown in Fig. 3. In control resting Mw
(condition 1), several cell surface proteins associated with CD4
were identified, including CD9, a tetraspanin-family member
involved in cell adhesion, cell motility and IL-16 signalling
[36,37,38,39]; CD163, involved in the clearance and endocytosis
of hemoglobin/haptoglobin complexes [40,41]; integrin subunit
beta (CD18), involved in cell surface adhesion and reported to
interact with integrins alpha-M and alpha-X [42]; protein S100, a
calcium binding protein known to be involved in phagocyte
migration and infiltration at sites of wounding [43]; chemokine
receptor 1 (CCR-1), a G protein-coupled receptor [44]; adaptor
protein 2 (AP-2), a known adaptor protein which functions in
protein transport via transport vesicles in different membrane
trafficking pathways [25,45], and HLA class I, involved in antigen
presentation [46]. CD4 was also found to be associated with
cytoskeleton and actin-modulating proteins, such as gelsolin,
tropomyosins and dynein. An unknown and uncharacterised
protein, TPP1 was also identified. A summary list of interacting
proteins is shown in table 1.
Anti-CD4 co-immunoprecipitation sub-proteome in
induced internalization and degradation
Internalization and degradation of CD4 in Mw was induced by
conditioned media from activated T cells (condition 2) and
interacting proteins were identified by CD4 co-immunoprecipi-
tation followed by LC-MS/MS. A representative gel of the
resolved proteins after CD4 co-immunoisolation is shown in
Fig. 3. Proteins identified included Cdc42, a small GTPase family
protein involved in signal transduction and endocytosis [47,48];
proteins associated with late endocytic trafficking, such as
LAMP1, a component of the lysosomal membrane [49,50];
RhoB, known to be associated with the late endosome
membrane; adaptor protein 1 (AP-1), a subunit of clathrin-
associated adaptor protein complex 1 [45,51,52]; Sec23B, a
component of coating protein II (COPII) involved in the
transport of vesicles from the Golgi apparatus to the endoplasmic
reticulum, and Rab10/Rab11B, important components of vesicle
recycling and protein turn-over [45,53]. Several cytoplasmic and
cytoskeleton-related proteins were also identified, including
fascin, myosin and tensin. Annexin A2, a calcium regulated
membrane binding protein and flotillin-1, a scaffolding protein
associated with caveolar membranes [54] were also identified
with more than 5 unique peptides. A complete list of the uniquely
identified proteins is shown in table 2.
Anti-CD4 co-immunoprecipitation sub-proteome in
induced internalization and blocked degradation
In condition 3, internalization of CD4 in Mw was induced by
the same conditioned media from activated T cells, as described
for condition 2, and cellular degradation was blocked using the
proteasome inhibitor MG132 and the vacuolar ATPase inhibitor
bafilomycin A1. CD4-interacting proteins were identified by co-
immunoprecipitations followed by LC-MS/MS. A representative
gel of the resolved proteins after CD4 co-immunoisolation is
shown in Fig. 3. CD4 was associated with a large number of
proteins related to protein degradation, in particular the protea-
some. Proteasome-related proteins such as the 26S regulatory
subunit 6B, ubiquitin-like modifier activating enzymes E1 and E3
ubiquitin protein ligase subunit Itch [55,56,57,58] were identified.
Figure 1. Strategy for the identification of CD4-complexes in human primary Mw. CD14
+ monocytes were isolated from human blood by
magnetic cell sorting (MACS) and cultured for 7 days in the presence of M-CSF. One hundred million day 7 fully differentiated Mw were left untreated
(Condition 1, blue), treated with conditioned media from activated T cells (Induced CD4 internalization and degradation, Condition 2 red) or treated
with conditioned media from activated T cells in the presence of the proteasomal inhibitor MG132 and the inhibitor of vacuolar ATPases bafilomycin
(BafA1) (Induced CD4 internalization but blocked degradation, Condition 3 green). Eighteen hours later, cells were detached from tissue culture
plates, lysed and large-scale anti-CD4 immunoprecipitations (IP) using monoclonal antibody against CD4 (clone QS4120) or isotype control IP were
carried out. IP products were loaded onto SDS-PAGE pre-cast gels and electrophoresis were run. Protein gels were coomassie stained, gel lanes were
cut into 10 equal pieces and trypsin-digested. Proteins were identified by LC-MS/MS.
doi:10.1371/journal.pone.0018690.g001
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protein trafficking were also identified, such as MHC-I molecules
(HLA-A and HLA-B), ERp29 and ERp1 (endoplasmic reticulum
chaperones) [59]. Although identified with one unique peptide,
but with high iProphet probability scores, we also detected 7
proteins, including components of vacuolar proton-transporting
ATPases, such as V-type proton ATPase subunits D and G1. A
complete list of the uniquely identified proteins is shown in table 3.
Table 4 lists the proteins commonly identified in all three
conditions.
Figure 2. CD4 is internalized and degraded after treatment with conditioned media from activated T cells. Mw were treated with
conditioned media from activated T cells for 18 hours or left untreated, followed by flow cytometry staining with directly conjugated mAb to CD4. A
Black histogram represents the appropriate isotype control. Histograms show the intensity of the signal on the X-axis with a log10-scale and the
percentage of maximum expression on the Y-axis. Representative staining of more than five donors tested (n.5). B Bars represent the mean
percentage of Mw expressing surface CD4 with SD error bars from ten independent donors (n=10). C Total CD4 expression levels (surface +
intracellular) were determined by dividing the geometrical MFI of the antibody staining over the MFI of the isotype control. Bars represent the mean
values of five independent donors (n=5) with SD error bars. In B and C, black bar corresponds to untreated Mw and white bar corresponds to
conditioned media treated Mw (T cell Sup).
doi:10.1371/journal.pone.0018690.g002
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in Mw
Mass spectrometry identifications of CD9, E3 ubiquitin ligase
Itch and clathrin heavy chain in CD4 co-immunoisolates were
confirmed by western blot analysis. As anticipated, CD4 was
identified in all Mw sample conditions, but at reduced levels in
condition 2. Clathrin heavy chain 1 was co-immunoisolated with
CD4 in all three conditions and the E3 ubiquitin ligase subunit Itch
was only co-immunoisolated with CD4 when cellular degradation
was blocked. CD9 antigen was only co-immunoisolated with CD4
in the control Mw. CCR5, reported to interact with CD4 at the
surface of Mw and T cells [60], was not identified by mass
spectrometry in any of the conditions described above and was not
detected bywesternblot analysis of CD4co-immunoisolates(Fig. 4).
GO annotations
Uniquely identified protein identifications in all three conditions
were exported to ProteinCenter and GO annotations were carried
out. In induced CD4 internalization and degradation (condition 2)
there is an over-representation of proteins associated with the
endosome, vacuole and Golgi, when compared to control Mw
(condition 1). Moreover, when cellular degradation is blocked
(condition 3) the over-represented CD4-associated proteins are
related to the proteasome, endoplasmic reticulum, organelle lumen,
mitochondrion and cytosol (Fig. 5A). Proteins related to DNA and
nucleotide-binding are over-represented in condition 3 and metal
binding proteins are over-represented in condition 2. No proteins
with structural molecular activities were uniquely identified in
condition 3, in contrast to control or condition 2, where 30% and
15%, respectively, of the uniquely identified proteins fall into this
category (Fig. 5B). Proteins related to cell organization and
biogenesis, cell differentiation, development and transport are greatly
over-represented in condition 2 over condition 3. In control Mw,
proteins related to response to stimulus and defence response are
over-represented over the other two. Cell motility-related proteins
cluster with CD4 in control Mw and in condition 2 (Fig. 5C).
Discussion
Mass spectrometry analysis of CD4 co-immunoisolates, supple-
mented with GO annotations provided useful information on the
clustering of CD4 molecules in resting Mw and elucidated the
protein-network involved in the internalization and degradation.
CD4 in resting Mw showed association with a range of molecules
found in the cellular cortex and membrane rafts. Consistent with
earlier reports [19,25,61], we also observed CD4 association, and
confirmed by western blotting, with components of clathrin-
mediated endocytosis, such as clathrin heavy chain 1 and the
adaptor protein AP-2, clearly suggesting that in resting Mw CD4
undergoes constitutive internalization and recycling [16,18,62]. AP-
2 hasbeenreportedtobeinvolvedintheinitial formationofclathrin
coated pits at the plasma membrane, and it is an important
mediator of receptor internalization and clathrin assembly [63]. We
observed CD4 association with the tetraspanin protein CD9, and as
both CD4 and CD9 are able to bind IL-16 in mast cells [36,64], this
association might in fact be physiologically relevant in Mw.
In addition to CD4, HIV-1 requires CXCR4 or CCR5 to enter
target cells. Xiao et al., reported a constitutive cell surface
association between CD4 and CCR5 [60] and showed that the
presence of gp120, leads to the clustering of CD4 and CCR5.
However, they stated that it was difficult to co-immunoisolate CD4
and CCR5 in human primary Mw and CD4
+ T cells in the absence
of gp120, arguingthat thelevelsofboth receptorswerevery lowand
the techniques used were not sensitive enough. Employing high-
resolution mass spectrometry analysis on a large sample of primary
Mw, a more sensitive technique than the one used by Xiao et al., we
did not detect CCR5 molecules in CD4 co-immunoisolates.
Although a constitutive CD4-CCR5 interaction in the absence of
gp120 might still exist, our results do not support this notion.
Many reports to date have shown that in CD4
+ T cells LCK
binds directly to the cytoplasmic tail of CD4 [13,16,18], providing
stability at the cell surface. As we did not identify any Src family
protein kinases in CD4 co-immunoisolates in Mw, it seems unlikely
that this kinase family plays a similarly prominent role in the
regulation of CD4 in Mw, as it does in T cells. This could also
explain the faster turn-over of CD4 in Mw compared to T cells.
Data from our laboratory showed that upon treatment with
conditioned media from activated T cells, CD4 expression in Mw
is down-regulated due to induced internalization and degradation
(Saraiva Raposo et al., manuscript under revision). Under this
condition, CD4 was associated with specific components of signal
transduction and transport pathways, including plasma mem-
brane-associated small GTPases, such as Cdc42, Ras-related
proteins and RhoB. The small GTPases of the Ras superfamily are
well known to have roles in endocytosis [65,66]. RhoB regulates
endosomal trafficking, in co-operation with mDia1 and Src kinase
[67], and Cdc42, which has also been connected to cell migration
and cell polarity, has also been linked to the regulation of
Figure 3. Representative protein gels of anti-CD4 immunopre-
cipitations in Mw. Mw were left untreated (Condition 1, blue), treated
with conditioned media from activated T cells (Condition 2, red) or
treated with conditioned media from activated T cells in the presence of
5 mM of MG132 and 100 nM of BafA1 (Condition 3, green). Eighteen
hours later, cells were lysed and anti-CD4 immunoprecipitations were
carried out. The final immunoisolates were resuspended in Laemmli
sample buffer under reducing and denaturing conditions, before
loading onto a SDS-PAGE pre-cast gel. Isotype control IgG immuno-
precipitations were also performed to show non-specific background
binding proteins.
doi:10.1371/journal.pone.0018690.g003
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LAMP1, suggesting the intervention of lysosomes in the down-
regulation of CD4. This observation correlates with the effect
induced by the phorbol ester PMA in the induction of CD4
internalization and degradation [69]. Overall, the over-represen-
tation of endosome-related proteins in this condition, clearly
clusters CD4 with the endocytic pathways.
When Mw are treated with conditioned media from activated T
cells in the presence of MG132 and bafilomycin A1, CD4 can still
be internalized, but it is not degraded (Saraiva Raposo et al.
manuscript under revision). Under this condition, CD4 was
associated with several components of the proteasome, such as
regulatory and activating subunits involved in the cascade of protein
ubiquitination, suggesting the involvement of the proteasomal
pathway. We identified the member of the E3 ubiquitin (Ub) ligase
family, Itch/AIP4 to be associated with CD4 and confirmed it by
western blot. Itch is a member of the HECT domain-containing E3
Ub ligases and has been implicated in the post-translational
Table 1. Uniquely identified proteins in anti-CD4 co-immunoprecipitations in control Mw (Condition 1).
PROTEIN NAME GENE
MOLECULAR
WEIGHT LOCALIZATION FUNCTION/STRUCTURE
UNIPROT
ACCESSION PROBABILITY
UNIQUE
PEPTIDES
Gelsolin, isoform 2 GSN 80,641 Cytoskeleton Actin-modulating protein P06396 1 14
Tropomyosin alpha-3
chain, isoform 2
TPM3 29,033 Cytoskeleton Actin-modulating protein P06753 1 6
Integrin beta 2 ITGB2 84,782 Membrane Cell adhesion P05107 1 5
Golgi autoantigen
(Golgin), subfamily
A2
GOLGA2 113,086 Golgi cis-Golgi structure Q08379 1 4
Tropomyosin alpha 4
chain, isoform 1
TPM4 28,522 Cytoskeleton Actin-modulating protein P67936 1 4
Putative
uncharacterized
protein TPP1
TPP1 60,369 Unknown Unknown B5MDC1 1 4
Coatomer, subunit
gamma
COPG 97,718 Cytoplasm Protein transport Q9Y678 1 3
Cytoplasmic dynein
1, heavy chain 1
DYNC1H1 532,408 Microtubules Motor protein Q14204 1 3
Hematopoietic
lineage cell-specific
protein
HCLS1 53,984 Membrane Antigen receptor signalling P14317 1 3
AP-2 complex
subunit beta,
isoform 1
AP2B1 104,553 Membrane Protein transport P63010 1 3
Protein S100-A9 S100A9 13,242 Membrane Chemotaxis P06702 1 3
Actin-related
protein 2/3
complex, subunit 1B
ARPC1B 40,950 Cytoplasm Actin binding O15143 1 2
Actin-related
protein 2/3
complex, subunit 4
ARPC4 19,667 Cytoplasm Actin binding P59998 1 2
F-actin capping
protein, subunit beta
CAPZB 37,482 Cytoplasm Actin binding B4DWA6 1 2
Scavenger receptor
(M130) cysteine-rich
CD163 125,437 Membrane Scavenger-receptor activity Q86VB7 1 2
HLA class I
histocompatibility
antigen
HLA-C 36,798 Membrane Antigen presentation Q29960 0.9998 2
Protein S100-A8 S100A8 10,835 Membrane Chemotaxis P05109 1 2
Ras-related C3
botulinum toxin
substrate 2
RAC2 21,429 Cytoplasm GTP binding P15153 1 2
Tropomyosin 1
alpha chain,
isoform 2
TPM1 32,678 Cytoskeleton Actin-modulating protein Q9Y427 0.9996 2
C-C chemokine
receptor type 1
CCR1 41,173 Membrane G-protein coupled receptor
protein
P32246 0.9888 2
CD9 antigen CD9 25,416 Membrane Signalling P21926 0.9952 2
Protein and gene names, molecular weight in Daltons, cellular localization, function/structure, Uniprot accession number, protein identification probability from
iProphet and unique number of identified peptides for each individual protein are shown.
doi:10.1371/journal.pone.0018690.t001
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cell surface by engagement to its cognate ligand SDF-1a [70].
In the early stages of HIV-1 infection, the viral protein HIV-1
Nef, reported to accelerate CD4 down-regulation, avoiding viral
superinfection and promoting efficient viral spread and optimal
viral particle production [25], also alters the intracellular
trafficking of MHC-I and MHC-II molecules [71]. HIV-1 Nef-
dependent reduction of surface MHC-I protects HIV-infected
primary T cells from recognition and killing by HIV-specific
cytotoxic T cells in vitro [72]. Schaefer et al. reported that HIV-1
Nef targets MHC-I molecules and CD4 for degradation in the
lysosomes, by showing co-localization of CD4 and a subset of
HLA-A2 proteins in late endosomes and multi-vesicular bodies
(MVB) [73]. We showed an interaction between CD4 and
components of MHC-I (HLA-A and HLA-B). Although, our
system is an HIV-1 Nef-independent system, both induced
pathways seem to have some degree of similarity.
Overall in resting macrophages CD4 shows association with a
range of proteins found in the cellular cortex, clathrin coated pits
and membrane rafts. In induced internalization the spectrum of
proteins clustered with the receptor changes and CD4 becomes
associated with components of signal transduction and transport.
Finally, under conditions where protein degradation pathways are
chemically blocked, CD4 associates with components of the
proteasome and ubiquitin-modifying proteins.
This is the first co-immunoisolation LC-MS/MS-based identi-
fication of CD4 complexes in human primary Mw elucidating
CD4-interacting proteins and the protein-network involved in its
induced internalization and degradation. Due to its importance in
the context of HIV-1 infection, revealing the CD4 ‘‘interactome’’
can lead to the discovery of important proteins in the pathogenesis
of the virus. In conclusion, our mass spectrometry data contribute
to a better understanding of the fate of CD4 molecules in resting
Mw and in induced internalization and degradation.
Table 2. Uniquely identified proteins in anti-CD4 co-immunoprecipitations in induced CD4 internalization and degradation in Mw
(Condition 2).
PROTEIN NAME GENE
MOLECULAR
WEIGHT LOCALIZATION FUNCTION/STRUCTURE
UNIPROT
ACCESSION PROBABILITY
UNIQUE
PEPTIDES
Actin, cytoplasmic 2 ACTG1 41,793 Cytoskeleton Actin binding P63261 0.9993 11
Annexin A2,
isoform 1
ANXA2 38,604 Membrane Calcium binding P07355 1 9
Alpha actinin 4 ACTN4 104,854 Cytoplasm Transport O43707 1 6
Flotillin 1 FLOT1 47,355 Membrane Protein transport O75955 0.99775 6
Protein transport
protein, Sec23B
SEC23B 86,479 COPII Vesicle Protein transport Q15437 1 5
Integrin beta ITGB2 78,345 Membrane Cell adhesion A8MYE6 0.99825 3
Fascin FSCN1 54,530 Cytoplasm Actin binding Q16658 1 2
Myosin-Va,
isoform 1
MYO5A 215,405 Cytoplasm Actin binding Q9Y4I1 1 2
Tensin 3, isoform 1 TNS3 155,266 Cytoplasm Protein binding Q68CZ2 0.9955 2
Cytosolic non-
specific
dipeptidase,
isoform 2
CNDP2 43,833 Cytoplasm Proteolysis Q96KP4 1 2
Reticulon 4,
isoform 2
RTN4 40,318 Membrane Protein binding Q9NQC3 1 2
Ras-related
protein, Rab-10
RAB10 22,541 Membrane Protein transport P61026 0.99775 2
Ribonuclease
inhibitor
RNH1 49,973 Cytoplasm Protein binding P13489 1 2
Cell division
control protein 42,
Isoform 1
CDC42 21,311 Cytoplasm/Membrane GTP binding P60953 0.9955 2
AP-1 complex
subunit beta 1,
Isoform A
AP1B1 104,637 Clathrin Coated Pits Endocytosis Q10567 0.9955 2
Lysosome
associated
membrane
glycoprotein 1
LAMP1 44,882 Lysosome Protein degradation P11279 0.9955 2
Ras-related
protein, Rab-11B
RAB11B 24,489 Membrane Protein transport Q15907 0.9965 2
Rho-related
GTP-binding
protein, RhoB
RHOB 22,123 Membrane Protein transport P62745 0.9876 2
Protein and gene names, molecular weight in Daltons, cellular localization, function/structure, Uniprot accession number, protein identification probability from
iProphet and unique number of identified peptides for each individual protein are shown.
doi:10.1371/journal.pone.0018690.t002
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Ethics statement
Adult human blood was obtained from anonymous donors
through the UK National Blood Service and tested negative for
HIV-1, hepatitis B/C, and syphilis. Local IRB approval was
sought for this work from Oxford University’s Central
University Research Ethics Committee (CUREC), and we were
informed that specific ethical approval was unnecessary for this
study, in accordance with their guidelines on the use of human
blood (http://www.admin.ox.ac.uk/curec/resrchapp/faqethapp.
shtml):
‘‘CUREC does not require an ethics form for laboratory research
using buffy coats. However there are occasions when the
Table 3. Uniquely identified proteins in anti-CD4 co-immunoprecipitations in induced CD4 internalization and blocked
degradation in Mw (Condition 3).
PROTEIN NAME GENE
MOLECULAR
WEIGHT LOCALIZATION FUNCTION/STRUCTURE
UNIPROT
ACCESSION PROBABILITY
UNIQUE
PEPTIDES
Heat shock 70 kDa
protein 1/2
HSPA1B 70,052 Cytoplasm Chaperone,
protein folding
P08107 1 19
Coronin 1C CORO1C 49,379 Cytoskeleton Signal transduction B4DMH3 1 3
Heme oxygenase 1 HMOX1 32,819 ER Metal-binding P09601 1 3
Guanine nucleotide-binding
protein G, isoform 2
GNAI2 38,473 Membrane GTP Binding, signal
Transduction
P04899 1 3
Annexin IV ANXA4 36,085 Cytoplasm Calcium binding Q6LES2 1 2
Annexin VI ANXA6 75,277 Cytoplasm Calcium binding A6NN80 0.7873 2
Endoplasmic reticulum
protein, ERp29
ERP29 28,993 ER lumen Intracellular protein
transport
P30040 1 2
Guanine nucleotide-binding
protein subunit beta 4
GNB4 37,567 Cytoplasm Transmembrane
signalling
Q9HAV0 0.9989 2
HLA class I
histocompatibility antigen
HLA-A 40,892 Membrane Antigen processing
and presentation
P16190 1 2
Hypoxia up-regulated
protein 1
HYOU1 111,335 ER lumen Chaperone,
protein folding
Q9Y4L1 1 2
E3 ubiquitin-protein
ligase Itchy, isoform 1
ITCH 102,803 Cytoplasm Protein
ubiquitination
Q96J02 1 2
Heterogeneous nuclear
ribonucleoprotein R
HNRNPR 70,943 Cytoplasm mRNA
processing
O43390 0.9931 2
Ras-related protein Rab-1A RAB1A 22,678 Membrane Protein transport P62820 0.9898 2
Endoplasmic reticulum
aminopeptidase 1, isoform 2
ERAP1 107,841 ER lumen Antigen processing
and presentation
Q9NZ08 1 2
Ras-related protein, Rab-1B RAB1B 22,171 Membrane Protein transport Q9H0U4 0.9898 2
26S protease regulatory
subunit 6B
PSMC4 47,366 Proteasome
Complex
Protein degradation P43686 0.9971 2
Proteasome activator
complex, subunit 1
PSME1 28,723 Proteasome
Complex
Protein degradation Q06323 0.9971 2
Proteasome subunit
alpha type 4
PSMA4 29,484 Proteasome
Complex
Protein degradation P25789 0.9971 2
Ubiquitin-like modifier-
activating enzyme 1
UBA1 117,849 Cytosol Ubiquitin conjugation
pathway
P22314 0.9971 2
Antigen peptide
transporter 1
TAP1 87,218 ER lumen Protein transport Q03518 0.9971 1
HLA class I
histocompatibility antigen
HLA-B 40,481 Membrane Antigen processing
and presentation
P30481 0.9971 1
Tyrosine-protein
phosphatase non-receptor
PTPN6 67,561 Cytoplasm Signal transduction P29350 0.9778 1
Ras-related protein, Rab-14 RAB14 23,897 Membrane Protein transport P61106 0.9971 1
Transmembrane emp24
domain-containing protein
TMED10 24,976 Golgi apparatus
membrane
Vesicular protein
trafficking
P49755 0.9971 1
V-type proton ATPase
subunit D
ATP6V1D 28,263 Vacuole Proton-transporting
ATPase
Q9Y5K8 0.9971 1
V-type proton ATPase
subunit G1
ATP6V1G1 13,758 Vacuole Proton-transporting
ATPase
O75348 0.9969 1
Protein and gene names, molecular weight in Daltons, cellular localization, function/structure, Uniprot accession number, protein identification probability from
iProphet and unique number of identified peptides for each individual protein are shown.
doi:10.1371/journal.pone.0018690.t003
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ethical approval from the University. In this instance a checklist
completion will suffice. Applicants should answer Question C (8)
as a ‘NO’. A covering note should be sent to the Secretary of the
MSD IDREC with the checklist explaining that the research uses
buffy coats and the NBS requires University ethical approval.’’
Although not required by NBS, we completed a checklist as
indicated and received exemption from MSD IREC.
Cells and reagents
PBMC were isolated using Ficoll-Plaque Plus (GE Healthcare
Life Sciences, Europe) density gradient centrifugation from
Table 4. Proteins commonly identified in all conditions.
PROTEIN NAME GENE
MOLECULAR
WEIGHT LOCALIZATION FUNCTION/STRUCTURE
UNIPROT
ACCESSION PROBABILITY
UNIQUE
PEPTIDES
Myosin 9, isoform 1 MYH9 226,532 Cytoplasm Actin binding P35579 1 126
Ras GTPase-activating-like protein IQGAP1 189,252 Membrane Ras GTPase activator
activity
P46940 0.99954 40
Major vault protein MVP 99,327 Cytoplasm Protein transport Q14764 1 35
Filamin A, isoform 2 FLNA 280,018 Cytoskeleton Protein binding P21333 1 34
Vimentin VIM 53,652 Cytosol Actin binding P08670 1 28
Plastin 2 LCP1 70,289 Cytoplasm Actin binding P13796 1 22
Clathrin heavy chain 1 CLTC 191,615 Clathrin coated pit Protein transport Q00610 1 20
Protein transport protein, Sec16A SEC16A 233,517 ER/Golgi Protein transport O15027 0.99478 19
Endoplasmin HSP90B1 92,469 Cytosol ERAD protein
catabolism
P14625 0.99998 13
Alpha actinin 1 ACTN1 103,058 Cytoskeleton Actin binding P12814 1 11
Talin 1 TLN1 269,767 Cytoskeleton Actin binding Q9Y490 0.9996 11
Moesin MSN 67,820 Cytoskeleton Cell adhesion P26038 1 10
DnaJ subfamily C member 10 DNAJC10 91,080 ER lumen Protein folding Q8IXB1 0.9977 9
CD4 antigen CD4 51,111 Membrane Receptor activity P01730 0.99942 9
Protein transport protein, Sec24C SEC24C 118,325 COPII vesicle ER/Golgi transport P53992 0.95185 8
Annexin A5 ANXA5 35,937 Cytoplasm Calcium binding P08758 0.9988 7
Profilin 1 PFN1 15,054 Cytoskeleton Actin binding P07737 0.99954 7
Protein disulfide isomerase P4HB 57,116 Membrane Protein disulfide
isomerase
P07237 0.99735 6
V-type proton ATPase, subunit B ATP6V1B2 56,501 Cytosol Proton-transporting
ATPase
P21281 0.99883 6
Calreticulin CALR 48,142 Cytosol Calcium binding P27797 0.9984 5
Cathepsin B CTSB 37,822 Lysosome Degradation/turn-over of
proteins
P07858 0.99787 5
Coronin 1A CORO1A 51,026 Cytoskeleton Actin binding P31146 0.99748 5
Cofilin 1 CFL1 18,502 Cytoskeleton Actin binding P23528 0.9987 4
F-actin-capping protein,
subunit alpha 2
CAPZA2 32,949 Cytoskeleton Actin binding P47755 0.9966 4
Protein transport protein, Sec24A SEC24A 119,749 COPII Vesicle ER/Golgi transport O95486 0.99903 4
Myeloid cell nuclear
differentiation antigen
MNDA 45,836 Cytoplasm Transcription regulation P41218 0.99806 4
Transferrin receptor protein 1 TFRC 84,871 Membrane Transferrin receptor
activity
P02786 0.9967 4
14-3-3 protein zeta/delta YWHAZ 27,745 Cytosol Signal transduction P63104 0.99913 3
Integrin alpha M CD11b 127,179 Membrane Cell adhesion P11215 0.99747 3
Protein-glutamine gamma-
glutamyltransferase 2
TGM2 77,329 Membrane Cell adhesion P21980 0.99808 3
Lymphocyte-specific protein 1 LSP1 37,192 Membrane Signal transduction P33241 0.99903 3
Macrophage-capping protein CAPG 38,518 Cytosol Actin binding P40121 0.99758 3
Ras-related protein, Rap-1b RAP1B 20,825 Membrane GTPase activity P61224 0.99743 3
IgE Fc receptor subunit gamma FCER1G 9,667 Membrane Receptor activity P30273 0.99773 2
Protein S100-A11 S100A11 11,740 Cytosol Calcium binding P31949 0.99883 2
Protein and gene names, molecular weight in daltons, cellular localization, function/structure, Uniprot accession number, protein identification probability from
iProphet and unique number of identified peptides for each individual protein are shown.
doi:10.1371/journal.pone.0018690.t004
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positive selection using anti-CD14 magnetic beads (Miltenyi
Biotec, UK), according to the manufacturer’s instructions and
seeded in complete medium (RPMI 10% FCS (PAA), 2 mM L-
glutamine (PAA), 100 U/mL penicillin (PAA) and 100 mg/mL
streptomycin (PAA)), supplemented with 50 ng/mL recombinant
M-CSF (R&D Systems) for 7 days. MG132 and bafilomycin A1
(BafA1) (Sigma, UK) were resuspended in DMSO (Sigma, UK)
and used at final non-toxic concentrations of 5 mM and 100 nM,
respectively. CD4
+ T Helper cells were isolated from the CD14-
negative population of PBMC, by negative selection (Miltenyi
Biotec, UK), according to the manufacturer’s protocol and
activated using anti-biotin MACSiBead particles and biotinylated
antibodies against human anti-CD2, CD3 and CD28 (Miltenyi
Biotec, UK) in complete medium for 3 days. Cell-free supernatants
were collected after 3 days stimulation, filtered (0.45 mm pore-size)
and stored until used. Typically, day 7 fully differentiated Mw
were treated with neat T cell supernatants, in the absent or
presence of MG132 and BafA1 for 18 hours, prior to CD4 co-
immunoisolation.
Flow cytometry
CD4 expression levels were detected by direct immunofluores-
cence. Mw in staining buffer (10 mg/mL human IgG (Sigma UK),
1% FCS and 0.01% NaN3) were incubated with 5 mg/mL anti-
CD4 specific mAb (clone RPA-T4, Becton Dickinson) or matched
isotype control (IgG1k, Becton Dickinson) on ice for 30–45 min.
For intracellular staining, cells were first fixed, then permeabilized
with 0.2% saponin (Sigma, UK) and stained. The percentage of
positive cells and the mean fluorescence intensity (MFI) were
analyzed by FACS Calibur (Becton Dickinson) with 15,000–
20,000-gated events collected. The data was processed using
FlowJo (version 7.2.4). Protein expression levels were determined
by dividing the geometrical MFI of the Ab staining over the MFI
of the isotype control.
Western blotting
Adherent Mw were washed free of media, detached using ice
cold 10 mM EDTA/PBS and cell pellets were lysed in ice-cold
lysis buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1% (v/v) n-
Dodecyl b-D-maltoside (Sigma), 16 protease inhibitor cocktail
(Roche), phosphatase inhibitor cocktail 2 (Sigma)). n-Dodecyl b-D-
maltoside is a water-soluble non-ionic detergent, shown to be a
rather gentle detergent able to preserve protein activity and
structure better than many commonly used agents, such as Triton
X-100, NP-40, CHAPs and octyl-b-glucoside [74,75,76,77].
Lysates were centrifuged for 10 min at 4uC, 13,0006g to separate
insoluble material and cleared lysate was resuspended in 16
Laemmli sample buffer (Invitrogen, UK) under reducing condi-
tions and heated for 10 min at 90uC. Lysates were electrophoresed
through SDS–PAGE gels and proteins were electroblotted to
PVDF transfer membranes. Blocked membranes were incubated
with one of the following primary antibodies diluted in 3% (w/v)
BSA (Sigma) in 16 PBS-T (16 PBS, 0.1% (v/v) Tween-20) for
2 hours at room temperature or over-night at 4uC: rabbit
polyclonal antibody anti-CD4 (clone H-370), rabbit polyclonal
antibody anti-CD9 (clone H-110), rabbit polyclonal antibody anti-
clathrin heavy chain 1 (clone H-300), rabbit polyclonal antibody
anti-E3 Ubiquitin ligase (clone H-110) (all from Santa Cruz) and
mouse monoclonal antibody anti-CCR5 (clone CTC5, R&D
Systems). Primary antibodies were detected using the matching LI-
COR secondary antibodies and membranes were scanned using
the quantitative western blotting imaging system Odyssey (LI-
COR).
Immunoisolation analysis
Anti-CD4 immunoisolation reactions consisted of 10 mLo f
protein G–Sepharose bead slurry (4B Fast Flow, Sigma, UK) per
1610
7 lysed cells and 5–10 mg mouse monoclonal antibody anti-
CD4 (clone QS4120, Santa Cruz) was incubated for 2 hours at
room temperature to allow binding of the antibody to the beads.
Beads were gently spun, cell lysate was added to the mixture of
beads/antibody and the reactions were incubated by inversion for
3 hours at 4uC. The immunoisolates were collected by centrifu-
gation for 5 min at 4uC, and washed three times for 5 min with
lysis buffer. The final immunoisolates were resuspended in
Laemmli sample buffer under reducing conditions and heated
for 10 min at 90uC, before loading them onto a gel. Isotype
control immunoprecipitations were also performed to identify
background binding proteins.
Mass spectrometry and protein identification
Anti-CD4 or isotype control immunoisolated pellets were
reduced in NuPAGE sample reducing agent (Invitrogen, UK),
separated on a NuPAGE Novex 4–12% Bis-Tris gel (Invitrogen,
UK) and coomassie stained. Gel lanes were excised, cut into 10
equal portions and in-gel digested with trypsin [78]. Briefly, gel
bands were diced into cubes and destained in 25 mM ammonium
bicarbonate in 50:50 water/acetonitrile. Proteins were reduced
with 10 mM DTT and alkylated with 55 mM iodoacetamide. Gel
bands were then incubated with 3 mg of trypsin (Promega, UK) in
25 mM ammonium bicarbonate over-night at 37uC. Peptides
were extracted and desalted using home-made C18 tips. Mass
spectrometry data were acquired on an Orbitrap mass spectrom-
Figure 4. Western blot analysis of CD4 co-immunoprecipitates
in Mw. A total of 1610
7 Mw were left untreated (Condition 1, blue),
treated for 18 hours with supernatants from activated T cells (Condition
2, red), treated for 18 hours with supernatants from activated T cells in
the presence of 5 mM MG132 and 100 nM BafA1 (Condition 3, green),
lysed and anti-CD4 immunoprecipitation reactions were carried out.
Isotype control immunoprecipitations were also performed to show
background protein binding. Immunoisolates were resuspended in
Laemmli sample buffer under reducing and denaturing conditions and
resolved on a SDS-PAGE gel. Membranes were incubated with
antibodies against CD4, clathrin heavy chain (HC) 1, E3 Ubiquitin (Ub)
ligase Itch, CD9 and CCR5. Primary antibodies were detected and
scanned using the quantitative western blotting imaging Odyssey
System. A representative blot of three different blood donors is shown
(n=3).
doi:10.1371/journal.pone.0018690.g004
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coupled to a U3000 nano HPLC system (Dionex, UK). The
samples were loaded onto a 15 cm long, 100 micron ID, home-
packed column manufactured by packing a Picotip emitter (New
Objective, USA) with ProntoSIL C18 phase; 120 angstrom pore, 3
micron bead, C18 (Bischoff Chromatography, Germany). HPLC
was run in a direct injection configuration. One hundred and
twenty minute gradients were used to resolve the peptides. The
Orbitrap was run in a data dependent acquisition mode in which
the Orbitrap resolution was set at 60,000 and the top 5 multiply
charged precursors were selected for MS/MS fragmentation.
Samples were typically injected three times in order to increase the
number and confidence of identifications. RAW data files were
converted to mzXML format using ReAdW (version 4.2.1) and
submitted to the in-house developed Central Proteomics Facilities
Pipeline (CPFP) [79]. The CPFP is based on the Trans Proteomic
Pipeline tools (version 4.2.1) [80] and implements automatic
identification of MS/MS spectra using multiple search engines to
maximise coverage of a sample. mzXML files were converted to
suitable peaklist formats for submission to Mascot (Matrix
Science), X!Tandem with k-score plugin [81] and OMSSA [82].
Searches are performed automatically and executed on a compute
cluster, using Sun GridEngine, and the resulting peptide
identifications from each search engine are validated with
PeptideProphet [83]. iProphet is used to combine peptide hits
from each three search engines and refines identification
probabilities. ProteinProphet infers protein identifications from
the resulting combined peptide list and performs grouping of
ambiguous hits [84]. Protein identifications were exported from
the CPFP and uploaded to ProteinCenter (Proxeon, Denmark) for
filtering, annotation, classification, and interpretation. Searches
were performed against a concatenated target/decoy human IPI
database providing an empirical false discovery rate (FDR) and
criteria for protein identification included 1% FDR and two or
more unique peptides identified for each individual protein.
Proteins that were identified in the isotype control immunopre-
cipitations were filtered out of the final interpretation. Uniquely
identified proteins were only identified in the condition tested and
commonly identified proteins were identified in all conditions
tested.
Statistical analysis
Statistical analysis was performed by paired t-test using
GraphPad Prism (version 5.01). Stars indicate the p-value:
**p=0.01-0.001; ***p,0.001. Significance refers to difference
from the controls, unless otherwise indicated. N refers to the
number of blood donors tested.
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